Comprehensive Metabolic Panel (CMP) Testing Market Report 2026

Comprehensive Metabolic Panel (CMP) Testing Market Overview

• Comprehensive Metabolic Panel (CMP) Testing market size has reached to $18.34 billion in 2025 • Expected to grow to $28.57 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Driving Forces In The Comprehensive Metabolic Panel (CMP) Testing Market Addressing The Rising Prevalence Of Cardiovascular Diseases And Diabetes • Market Trend: Advancements In Integrated Diagnostic Platforms Accelerate Automated Clinical Chemistry Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Comprehensive Metabolic Panel (CMP) Testing Market?

A comprehensive metabolic panel (CMP) test is a blood test containing 14 separate parameters that offer crucial knowledge about the body's chemical equilibrium and metabolism. It is frequently used to assess nutritional levels, liver and kidney function, and diagnosis, screening, and monitoring. The main comprehensive metabolic panel (CMP) testing diseases are kidney disease, liver disease, diabetes, and others. Kidney disease refers to a damaged kidney that is unable to adequately execute its functions, such as blood filtering. The various test types are proteins, electrolytes, kidney tests, liver functional tests, and glucose used in laboratories, and point of care (PoC).

What Is The Comprehensive Metabolic Panel (CMP) Testing Market Growth Forecast?

The comprehensive metabolic panel (cmp) testing market size is expected to see strong growth in the next few years. It will grow to $28.57 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic solutions, expansion of decentralized testing models, rising adoption of integrated lab automation, growing focus on population health screening, increasing investments in diagnostic infrastructure. Major trends in the forecast period include increasing adoption of automated clinical chemistry analyzers, rising demand for routine metabolic screening, growing integration of laboratory information systems, expansion of point-of-care cmp testing, enhanced focus on early disease detection.

Global Comprehensive Metabolic Panel (CMP) Testing Market Segmentation

1) By Disease: Kidney Disease, Liver Disease, Diabetes, Other Diseases 2) By Test Type: Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose 3) By End User: Laboratories, Point Of Care (PoC) Subsegments: 1) By Kidney Disease: Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI), Glomerulonephritis 2) By Liver Disease: Hepatitis (Viral And Non-Viral), Cirrhosis, Fatty Liver Disease 3) By Diabetes: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes 4) By Other Diseases: Cardiovascular Diseases, Electrolyte Imbalances, Metabolic Disorders, Pancreatic Diseases

What Is The Driver Of The Comprehensive Metabolic Panel (CMP) Testing Market?

The increasing prevalence of cardiovascular diseases and diabetes is expected to propel the growth of the comprehensive metabolic panel (CMP) testing market going forward. Cardiovascular disorders affect the heart or blood vessels and are linked to atherosclerosis, the build-up of fatty deposits inside the arteries. Diabetes is a condition that develops when blood glucose levels are too high. Comprehensive metabolic panel (CMP) blood tests detect glucose levels. Thus, with the increasing cases of diabetes and cardiovascular diseases, the need for their diagnosis through blood tests such as the CMP blood test will support the market's growth. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for one in every three deaths. Coronary heart disease remained the most prevalent form of heart disease, and notably, about one in six deaths from cardiovascular diseases occurred among adults younger than 65 years. Therefore, the increasing prevalence of cardiovascular diseases and diabetes is driving the growth of the comprehensive metabolic panel (CMP) testing industry.

Key Players In The Global Comprehensive Metabolic Panel (CMP) Testing Market

Major companies operating in the comprehensive metabolic panel (cmp) testing market are Abbott Laboratories Inc., Siemens Healthineers AG, Mayo Clinic, Laboratory Corporation of America Holdings, Mercy, Mount Sinai Health System, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Hologic Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Werfen SA, DiaSorin S.p.A., Randox Laboratories Ltd., ARUP Laboratories Inc., Invitae Corporation, Abaxis Inc., Metropolis Healthcare Limited, Clinical Reference Laboratory (CRL), Centogene AG, Spectra Laboratories, Unipath Systems Ltd., Scion Lab Services LLC, Weldon Biotech Pvt Ltd., Corona Pathology,Ulta Lab Tests LLC, Any Lab Test Now, Applied InGENuity Diagnostics LLC, Walk-In Lab LLC

Global Comprehensive Metabolic Panel (CMP) Testing Market Trends and Insights

Major companies operating in the comprehensive metabolic panel (CMP) testing market are focusing on developing advanced solutions such as integrated clinical chemistry and immunoassay analyzers to deliver faster, more efficient, and consolidated CMP testing workflows. Integrated clinical chemistry and immunoassay analyzers are single, combined systems that perform both chemistry and immunoassay tests on one platform, helping laboratories speed up testing, reduce manual steps, and consolidate CMP and related panels for more efficient workflows and faster results. For instance, in July 2023, Siemens Healthineers AG, a Germany-based medical technology company, launched the Atellica CI Analyzer, an integrated clinical chemistry and immunoassay system that targets labs needing compact, high-quality CMP workflows. The Atellica CI Analyzer is a modular, random-access platform that pairs chemistry and immunoassay capabilities in a single footprint, supports a broad and expanding assay menu, and uses digitized workflows and advanced reporting to improve turnaround and sample traceability. It features automated sample management and priority testing, built-in diagnostics and IT connectivity for LIS/HIS integration, and an assay development pipeline that lets labs consolidate CMP testing and related panels on one system, enabling faster clinician decisioning and lower hands-on time versus routing samples across multiple instruments.

What Are Latest Mergers And Acquisitions In The Comprehensive Metabolic Panel (CMP) Testing Market?

In March 2023, Fluxergy, a US-based medical diagnostic company, acquired specific staff, assets, and authorized electrochemical biosensing technologies from InnaMed Inc. for an undisclosed amount. Through this acquisition, Fluxergy broadens its detection capabilities to encompass clinical chemistry and small molecules in human, horse, and small animal veterinary care. InnaMed Inc. is a US-based decentralized blood testing company through electrochemical biosensor technology.

Regional Outlook

North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Comprehensive Metabolic Panel (CMP) Testing Market?

The comprehensive metabolic panel (CMP) testing market includes revenues earned by entities by providing glucose tests, sodium tests, and albumin tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Comprehensive Metabolic Panel (CMP) Testing Market Report 2026?

The comprehensive metabolic panel (cmp) testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the comprehensive metabolic panel (cmp) testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.